Class information for:
Level 1: BIOCHEM BIOTECH DRUGS//CEREBROVASCULAR THROMBOSIS//EXTRAINTESTINAL COMPLICATION

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
12702 825 34.4 74%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
88 25697 ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 BIOCHEM BIOTECH DRUGS Address 2 67% 0% 2
2 CEREBROVASCULAR THROMBOSIS Author keyword 2 67% 0% 2
3 EXTRAINTESTINAL COMPLICATION Author keyword 2 67% 0% 2
4 HLTH CLIN DATA Address 2 67% 0% 2
5 PHOSPHOLIPID BINDING ANTIBODIES Author keyword 2 67% 0% 2
6 GASTROENTEROL GASTROINTESTINAL ENDOSCOPY SERV Address 2 21% 1% 8
7 COLITIS ULCERATIVE DRUG THERAPY Author keyword 1 50% 0% 2
8 HEPARIN LOW MOLECULAR WEIGHT ADVERSE EFFECTS THERAPEUTIC USE Author keyword 1 50% 0% 2
9 SYSTEMIC INFECTIOUS COMPLICATIONS Author keyword 1 100% 0% 2
10 PROPAEDEUT INTERNAL MED 2 Address 1 17% 1% 6

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
LCSH search Wikipedia search
1 CEREBROVASCULAR THROMBOSIS 2 67% 0% 2 Search CEREBROVASCULAR+THROMBOSIS Search CEREBROVASCULAR+THROMBOSIS
2 EXTRAINTESTINAL COMPLICATION 2 67% 0% 2 Search EXTRAINTESTINAL+COMPLICATION Search EXTRAINTESTINAL+COMPLICATION
3 PHOSPHOLIPID BINDING ANTIBODIES 2 67% 0% 2 Search PHOSPHOLIPID+BINDING+ANTIBODIES Search PHOSPHOLIPID+BINDING+ANTIBODIES
4 COLITIS ULCERATIVE DRUG THERAPY 1 50% 0% 2 Search COLITIS++ULCERATIVE+DRUG+THERAPY Search COLITIS++ULCERATIVE+DRUG+THERAPY
5 HEPARIN LOW MOLECULAR WEIGHT ADVERSE EFFECTS THERAPEUTIC USE 1 50% 0% 2 Search HEPARIN++LOW+MOLECULAR+WEIGHT+ADVERSE+EFFECTS+THERAPEUTIC+USE Search HEPARIN++LOW+MOLECULAR+WEIGHT+ADVERSE+EFFECTS+THERAPEUTIC+USE
6 SYSTEMIC INFECTIOUS COMPLICATIONS 1 100% 0% 2 Search SYSTEMIC+INFECTIOUS+COMPLICATIONS Search SYSTEMIC+INFECTIOUS+COMPLICATIONS
7 HEPARIN ADVERSE EFFECTS THERAPEUTIC USE 1 40% 0% 2 Search HEPARIN+ADVERSE+EFFECTS+THERAPEUTIC+USE Search HEPARIN+ADVERSE+EFFECTS+THERAPEUTIC+USE
8 ARTERIAL THROMBOEMBOLISM 1 13% 1% 6 Search ARTERIAL+THROMBOEMBOLISM Search ARTERIAL+THROMBOEMBOLISM
9 ANTICOAGULANTS ADVERSE EFFECTS THERAPEUTIC USE 1 33% 0% 2 Search ANTICOAGULANTS+ADVERSE+EFFECTS+THERAPEUTIC+USE Search ANTICOAGULANTS+ADVERSE+EFFECTS+THERAPEUTIC+USE
10 ALPHA AND BETA CAROTENES 1 50% 0% 1 Search ALPHA++AND+BETA+CAROTENES Search ALPHA++AND+BETA+CAROTENES

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 GASTROCNEMIUS MYOSITIS 21 90% 1% 9
2 FACTOR XIII POLYMORPHISM 9 83% 1% 5
3 COLONIC RELEASE 6 100% 0% 4
4 REDUCTASE C677T VARIANT 3 57% 0% 4
5 PROTHROMBIN GENE MUTATION 2 16% 1% 11
6 FREE PROTEIN S 2 36% 0% 4
7 MULTIFOCAL GASTROINTESTINAL INFARCTION 2 36% 0% 4
8 MUCOSAL MICROCIRCULATION 1 33% 0% 3
9 UNFRACTIONED HEPARIN 1 33% 0% 3
10 CEREBRAL SINUS THROMBOSIS 1 22% 0% 4

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 2007 137 109 70%
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 2014 17 43 49%
Epidemiology, risk factors and management of cardiovascular diseases in IBD 2015 1 88 40%
Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A meta-analysis of observational studies 2014 16 64 36%
Inflammatory Bowel Disease: A Paradigm for the Link Between Coagulation and Inflammation 2009 35 65 55%
Cerebral arterial infarction in inflammatory bowel diseases 2014 7 49 67%
Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? 2015 1 97 28%
Venous and arterial disease in inflammatory bowel disease 2013 14 133 53%
Thrombosis and Inflammatory Bowel Disease: A Call for Improved Awareness and Prevention 2011 32 99 53%
Inflammatory bowel disease-associated thromboembolism: A systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis 2012 11 48 63%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 BIOCHEM BIOTECH DRUGS 2 67% 0.2% 2
2 HLTH CLIN DATA 2 67% 0.2% 2
3 GASTROENTEROL GASTROINTESTINAL ENDOSCOPY SERV 2 21% 1.0% 8
4 PROPAEDEUT INTERNAL MED 2 1 17% 0.7% 6
5 WINDSOR PROGRAM 1 40% 0.2% 2
6 AHEPA GEN HOSP THESSALONIKI 1 50% 0.1% 1
7 ALMA MATER STUDIORUM INFECT DIS 1 50% 0.1% 1
8 BIANCHI BONOMI HAEMOPHILIA THROMBOSIS 1 50% 0.1% 1
9 CARDIOLCARDIAC MR PET CT PROGRAM 1 50% 0.1% 1
10 CHRISTIAN DOPPLER KLINK 1 50% 0.1% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000229569 EXTRAINTESTINAL MANIFESTATIONS//EXTRAINTESTINAL MANIFESTATION//LUNG BEING CONNECTED WITH LARGE INTESTINE
2 0.0000072723 EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE//MONTREAL CLASSIFICATION//INDETERMINATE COLITIS
3 0.0000062574 DRUG INDUCED LUPUS//DRUG INDUCED LUPUS ERYTHEMATOSUS//TNF ALPHA ANTAGONISTS
4 0.0000062129 INTESTINAL FIBROSIS//SUBEPITHELIAL FIBROBLASTS//SECT BRAIN STRUCT
5 0.0000055577 SEVERE ULCERATIVE COLITIS//TOXIC MEGACOLON//STEROID REFRACTORY ULCERATIVE COLITIS
6 0.0000051437 ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES//ASCA//ANTI SACCHAROMYCES CEREVISIAE ANTIBODY
7 0.0000050326 FECAL CALPROTECTIN//CALPROTECTIN//FECAL ALPHA 1 ANTITRYPSIN
8 0.0000048727 ACETIC ACID INDUCED COLITIS//EXPERIMENTAL COLITIS//COLONIC PERFUSION
9 0.0000047750 PORTAL VEIN THROMBOSIS//PORTAL BILIOPATHY//REX SHUNT
10 0.0000046804 CEREBRAL VENOUS THROMBOSIS//CEREBRAL VENOUS SINUS THROMBOSIS//SINUS THROMBOSIS